Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T22:16:46.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer updates its site revision from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T22:05:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A minor UI text update for the contact information link and a new revision badge (v3.7.0) replacing the previous badge (v3.6.6) appear in the study record history, indicating a small interface change and a platform version update.
    Difference
    0.3%
    Check dated 2026-09-20T21:00:53.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The Study Record History now lists revision v3.6.6, with v3.6.5 removed from the history. This indicates an update to the page's revision history and versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-30T22:01:19.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The record history now shows a new revision version v3.6.5, replacing the previous v3.6.4. This reflects a system/UI update to the page rather than a change to the study content.
    Difference
    0.1%
    Check dated 2026-08-09T11:15:59.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    New revision entry added: Revision: v3.6.4, and Revision: v3.6.3 removed from the record history. This update changes only the version history on the page and does not affect trial data or content.
    Difference
    0.1%
    Check dated 2026-07-25T18:24:01.000Z thumbnail image

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.